<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2023.1106340</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>ArcR contributes to tolerance to fluoroquinolone antibiotics by regulating <italic>katA</italic> in <italic>Staphylococcus aureus</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Tongtong</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="fn0003" ref-type="author-notes"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Zheng</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="fn0003" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/410585/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yujie</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="fn0003" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1585940/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Zhoufei</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Bing</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Shiyu</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Xiaohu</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Rui</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Hanqing</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Yanling</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1424261/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xue</surname>
<given-names>Guanhua</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/893711/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cui</surname>
<given-names>Jinghua</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/713193/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yan</surname>
<given-names>Chao</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/893712/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gan</surname>
<given-names>Lin</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feng</surname>
<given-names>Junxia</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1513148/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Ziying</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1147868/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Zihui</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2159013/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Ziyan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Zanbo</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Jinfeng</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Yujie</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuan</surname>
<given-names>Jing</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/180594/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Bacteriology, Capital Institute of Pediatrics</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Life Science and Medicine, University of Science and Technology of China</institution>, <addr-line>Hefei</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Military Supplies and Energy Quality Supervision Station of NV, PLA</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by"><p>Edited by: Rami M. Elshazli, Horus University, Egypt</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Reviewed by: Marat R. Sadykov, University of Nebraska Medical Center, United States; Jianhua Yin, Zhejiang University of Technology, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Jing Yuan, <email>yuanjing6216@163.com</email></corresp>
<fn id="fn0003" fn-type="equal"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn id="fn0004" fn-type="other"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1106340</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Fu, Fan, Li, Li, Du, Liu, Cui, Zhang, Zhao, Feng, Xue, Cui, Yan, Gan, Feng, Xu, Yu, Tian, Ding, Chen, Chen and Yuan.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Fu, Fan, Li, Li, Du, Liu, Cui, Zhang, Zhao, Feng, Xue, Cui, Yan, Gan, Feng, Xu, Yu, Tian, Ding, Chen, Chen and Yuan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p><italic>Staphylococcus aureus</italic> is an opportunistic pathogen that shows a unique ability to quickly respond to a variety of antibiotics. The Crp/Fnr family transcriptional regulator ArcR controls expression of arginine deiminase pathway genes <italic>arcABDC</italic>, which enable the utilization of arginine as an energy source for cell growth under anaerobic conditions. However, ArcR shares low overall similarity with other Crp/Fnr family proteins, suggesting that they differ in the response to environmental stress. In this study, MIC and survival assays were performed to determine the role of ArcR in antibiotic resistance and tolerance. The results showed that deletion of <italic>arcR</italic> reduced tolerance of <italic>S.aureus</italic> to fluoroquinolone antibiotics, mainly through a defect in the response to oxidative stress. In <italic>&#x0394;arcR</italic> mutant, the expression of the major catalase gene <italic>katA</italic> was downregulated, and <italic>katA</italic> overexpression restored bacterial resistance to oxidative stress and antibiotics. We showed that ArcR directly regulated <italic>katA</italic> transcription by binding to the promoter region of <italic>katA</italic>. Therefore, our results revealed the contribution of ArcR in bacterial tolerance to oxidative stress and subsequently to fluoroquinolones antibiotics. This study added our understanding on the role of Crp/Fnr family in bacterial susceptibility to antibiotics.</p>
</abstract>
<kwd-group>
<kwd><italic>Staphylococcus aureus</italic></kwd>
<kwd>ArcR</kwd>
<kwd>fluoroquinolone antibiotics</kwd>
<kwd>oxidative stresses</kwd>
<kwd>catalase</kwd>
<kwd>KatA</kwd>
</kwd-group>
<contract-num rid="cn1">82130065</contract-num>
<contract-num rid="cn2">32170201</contract-num>
<contract-num rid="cn2">82002191</contract-num>
<contract-num rid="cn3">7222014</contract-num>
<contract-num rid="cn4">FFBR 202103</contract-num>
<contract-num rid="cn5">CXYJ-2021-04</contract-num>
<contract-sponsor id="cn1">National Natural Science Foundation for Key Programs of China Grants</contract-sponsor>
<contract-sponsor id="cn2">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></contract-sponsor>
<contract-sponsor id="cn3">Beijing Natural Science Foundation<named-content content-type="fundref-id">10.13039/501100004826</named-content></contract-sponsor>
<contract-sponsor id="cn4">FENG foundation</contract-sponsor>
<contract-sponsor id="cn5">Research Foundation of Capital Institute of Pediatrics</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="38"/>
<page-count count="9"/>
<word-count count="5818"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p><italic>Staphylococcus aureus</italic> is one of the most common pathogens worldwide and causes a variety of diseases from mild skin infection to fatal endocarditis and sepsis (<xref ref-type="bibr" rid="ref20">Levy and Marshall, 2004</xref>; <xref ref-type="bibr" rid="ref4">Cheung et al., 2021</xref>). Antibacterial therapy is one of the only curative pharmacological treatments. Antibiotics exert a bacteriostatic or bactericidal effect by interacting with their targets, <italic>via</italic> three main mechanisms: inhibition of DNA replication or RNA transcription; disruption of protein synthesis; and prevention of cell wall renewal (<xref ref-type="bibr" rid="ref30">Walsh, 2000</xref>). Several studies showed that aminoglycoside, &#x03B2;-lactam, and quinolone antibiotics, regardless of drug-target interactions, could stimulate the formation of highly deleterious hydroxyl radicals that assist the bactericidal process (<xref ref-type="bibr" rid="ref17">Imlay and Fridovich, 1991</xref>; <xref ref-type="bibr" rid="ref7">Dwyer et al., 2007</xref>; <xref ref-type="bibr" rid="ref18">Kohanski et al., 2007</xref>). It was well accepted that majority of superoxide generation in <italic>E. coli</italic> occurs through oxidation of the respiratory electron transport chain driven by oxygen and the conversion of NADH to NAD<sup>+</sup>. NADH is generated from NAD<sup>+</sup> during the TCA cycle. Aminoglycoside, &#x03B2;-lactam, and quinolone antibiotics could result in catabolic NADH depletion, which facilitated the strengthening of the TCA cycle and the generation of superoxide such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Then, superoxide could stimulate the Fenton reaction that produced hydroxyl radicals (<xref ref-type="bibr" rid="ref17">Imlay and Fridovich, 1991</xref>; <xref ref-type="bibr" rid="ref7">Dwyer et al., 2007</xref>). All three of these types of bactericidal antibiotics stimulate the production of highly harmful reactive oxygen species (ROS) in both Gram-negative and Gram-positive bacteria, which ultimately help to kill bacteria (<xref ref-type="bibr" rid="ref18">Kohanski et al., 2007</xref>; <xref ref-type="bibr" rid="ref27">Singh et al., 2021</xref>).</p>
<p>In natural or host immune system environment, bacteria respond to various reactive species that could modify the bacterial proteome by post-translational modifications and result in bacterial defense through dedicated signal transduction pathways. The reactive species include ROS that are generated in bacteria as the unavoidable consequence of the aerobic life, by incomplete reduction of molecular oxygen during respiration (<xref ref-type="bibr" rid="ref15">Imlay, 2003</xref>, <xref ref-type="bibr" rid="ref16">2008</xref>). The ROS are composed by superoxide anion O<sub>2</sub>&#x2022;<sup>&#x2212;</sup>, H<sub>2</sub>O<sub>2</sub>, and the highly reactive OH&#x2022;. Catalases and peroxidases are the major peroxide scavengers that convert H<sub>2</sub>O<sub>2</sub> to H<sub>2</sub>O and O<sub>2</sub> through different mechanisms. Catalases have an extremely high peroxide turnover rate and make function at high H<sub>2</sub>O<sub>2</sub> concentrations. In <italic>S. aureus</italic>, the major catalase KatA is present that is peroxide-inducible and confers H<sub>2</sub>O<sub>2</sub> resistance. Mutations in the gene encoding catalase increase antibiotic susceptibility in <italic>Burkholderia</italic>. In <italic>Pseudomonas aeruginosa</italic>, mutation of <italic>katA</italic> results in increased susceptibility to ciprofloxacin, aminoglycosides, and &#x03B2;-lactam antibiotics (<xref ref-type="bibr" rid="ref34">Yu and Deutscher, 1995</xref>).</p>
<p>Members of the Crp/Fnr family are DNA-binding proteins that function as transcriptional regulators which primarily activate the expression of genes, although some also repress the expression (<xref ref-type="bibr" rid="ref19">K&#x00F6;rner et al., 2003</xref>). ArcR belongs to the Crp/Fnr family regulators, whose gene <italic>arcR</italic> and arginine deiminase pathway genes <italic>arcABDC</italic> form an operon in <italic>S. aureus</italic>. There was 19% identity and 45% similarity between the ArcR open reading frame of <italic>S. aureus</italic> and <italic>Bacillus licheniformis</italic>, but less similarity compared with Crp of <italic>Escherichia coli</italic>. Under anaerobic conditions, ArcR binds to the upstream regulatory regions of <italic>arcABDC</italic> to positively regulate their transcription, and this process can be influenced by glucose and arginine (<xref ref-type="bibr" rid="ref22">Makhlin et al., 2007</xref>). Apart from this regulatory process, the role of ArcR in the response of <italic>S. aureus</italic> to environmental stress, such as antibiotics, remains unknown.</p>
<p>In this study, we found that ArcR played an important role in the resistance of <italic>S. aureus</italic> to fluoroquinolones antibiotics. When <italic>arcR</italic> was deleted, <italic>S. aureus</italic> had a reduced response to oxidative stress. We further demonstrated that ArcR positively regulated the transcription level of <italic>katA</italic> by directly binding to the promoter region of <italic>katA</italic>, thereby affecting the tolerance of bacteria to oxidative stress and fluoroquinolone antibiotics.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec3">
<title>Bacterial strains, plasmids, and growth conditions</title>
<p>The bacterial strains and plasmids used in this study are listed in <xref rid="tab1" ref-type="table">Table 1</xref>. The primers used are listed in <xref rid="tab2" ref-type="table">Table 2</xref>. When necessary, the corresponding antibiotics (100&#x2009;&#x03BC;g/ml ampicillin and 50&#x2009;&#x03BC;g/ml kanamycin) were added to the medium. <italic>S. aureus</italic> was usually cultured in Tryptone Soy Broth medium at 37&#x00B0;C and 220&#x2009;rpm, to which 15&#x2009;&#x03BC;g/ml chloramphenicol and 10&#x2009;&#x03BC;g/ml erythromycin were added when necessary.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Bacterial strains and plasmids used in this study.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Strain or plasmid</th>
<th align="left" valign="top">Relevant characteristic</th>
<th align="center" valign="top">Source or reference</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="3"><italic>S. aureus</italic></td>
</tr>
<tr>
<td align="left" valign="top">RN4220</td>
<td align="left" valign="top">8,325&#x2013;4, r<sup>&#x2212;</sup>, restriction-deficient mutagenized RN450</td>
<td align="center" valign="top">(<xref ref-type="bibr" rid="ref003">Kreiswirth et al., 1983</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">NCTC8325 WT</td>
<td align="left" valign="top">NCTC8325 wild-type strain</td>
<td align="center" valign="top">NASA<xref rid="tfn1" ref-type="table-fn"><sup>a</sup></xref></td>
</tr>
<tr>
<td align="left" valign="top">NCTC8325 &#x0394;<italic>arcR</italic></td>
<td align="left" valign="top">NCTC8325 <italic>arcR</italic> deletion mutant</td>
<td align="center" valign="top">This study</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3"><italic>E. coli</italic></td>
</tr>
<tr>
<td align="left" valign="top">DH5&#x03B1;</td>
<td align="left" valign="top"><italic>E. coli</italic> host for cloning</td>
<td align="center" valign="top">Vazyme</td>
</tr>
<tr>
<td align="left" valign="top">BL21(DE3)</td>
<td align="left" valign="top">Express strain; F<sup>&#x2212;</sup> <italic>ompT hsdS</italic><sub>B</sub> (r<sub>B</sub><sup>&#x2212;</sup> m<sub>B</sub><sup>&#x2212;</sup>) <italic>gal dcm</italic> (DE3)</td>
<td align="center" valign="top">Vazyme</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Plasmid</td>
</tr>
<tr>
<td align="left" valign="top">pBTs</td>
<td align="left" valign="top"><italic>E. coli/S. aureus</italic> temp-sensitive plasmid, Apr<sup>b</sup>, Cmr, for the construction of allelic-exchange mutants</td>
<td align="center" valign="top">(<xref ref-type="bibr" rid="ref001">Bae and Schneewind, 2006</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">pBTs-<italic>arcR</italic></td>
<td align="left" valign="top">pBTs derivative, for <italic>arcR</italic> deletion</td>
<td align="center" valign="top">This study</td>
</tr>
<tr>
<td align="left" valign="top">pCN51</td>
<td align="left" valign="top"><italic>E. coli/S. aureus</italic> expression vector, Apr<sup>b</sup>, Emr</td>
<td align="center" valign="top">(<xref ref-type="bibr" rid="ref002">Charpentier et al., 2004</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>arcR</italic></td>
<td align="left" valign="top">Inducible expression <italic>arcR</italic> in <italic>S. aureus</italic></td>
<td align="center" valign="top">This study</td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>katA</italic></td>
<td align="left" valign="top">Inducible expression <italic>katA</italic> in <italic>S. aureus</italic></td>
<td align="center" valign="top">This study</td>
</tr>
<tr>
<td align="left" valign="top">pET28a</td>
<td align="left" valign="top">Expression vector with His tag in <italic>E. coli</italic>, Kmr</td>
<td align="center" valign="top">Addgene</td>
</tr>
<tr>
<td align="left" valign="top">pET28a-<italic>arcR</italic></td>
<td align="left" valign="top">His6-ArcR expression vector</td>
<td align="center" valign="top">This study</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1"><label>a</label><p>NARSA, network on antimicrobial resistance in <italic>S. aureus</italic>.</p></fn>
<p><sup>b</sup> Ap, ampicillin; Cm, chloramphenicol; Em, erythromycin; Km, kanamycin.</p>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Primers used in this study.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Name</th>
<th align="left" valign="top">Sequence (5&#x2032;-3&#x2032;)</th>
<th align="left" valign="top">Purpose</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">RarcR-UP-F-EcoRI</td>
<td align="left" valign="top">ATCGCAGTGCAGCGGAATTCTTGTGGTGCAATGTCACAGGGTATG</td>
<td align="left" valign="top" rowspan="4"><italic>arcR</italic> deletion</td>
</tr>
<tr>
<td align="left" valign="top">RarcR-UP-R</td>
<td align="left" valign="top">TGTTTGCTTACTAACCAATCTGCTAATGCCTTTAGTTCATG</td>
</tr>
<tr>
<td align="left" valign="top">RarcR-DN-F</td>
<td align="left" valign="top">CATGAACTAAAGGCATTAGCAGATTGGTTAGTAAGCAAACA</td>
</tr>
<tr>
<td align="left" valign="top">RarcR-DN-R-HindIII</td>
<td align="left" valign="top">AAACTACCGCATTAAAGCTTAGCATCAGCAGCATTTACTACCG</td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>arcR</italic>-F</td>
<td align="left" valign="top">GGTCAATGTCTGAACCTGCAG AGTTGTCTGCTGACACTTTGC</td>
<td align="left" valign="top" rowspan="2">Expression of <italic>arcR</italic> in <italic>S. aureus</italic></td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>arcR</italic>-R</td>
<td align="left" valign="top">TCCTCTAGAGTCGACCTGCAGTACGTTAGACCTCATGTTCAAC</td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>katA</italic>-F</td>
<td align="left" valign="top">GGTCAATGTCTGAACCTGCAGATGTGTCTTGAGTTAAGACTACG</td>
<td align="left" valign="top" rowspan="2">Expression of <italic>katA</italic> in <italic>S. aureus</italic></td>
</tr>
<tr>
<td align="left" valign="top">pCN51-<italic>katA</italic>-R</td>
<td align="left" valign="top">TCCTCTAGAGTCGACCTGCAGTCTCTTGTTAGGAATCTTTACG</td>
</tr>
<tr>
<td align="left" valign="top">pET28a-<italic>arcR</italic>-F</td>
<td align="left" valign="top">TTGAAGGAGTTTAACTTATGCATCATCATCATCATCACACAGAAAACTTTATTTTGG</td>
<td align="left" valign="top">Expression of</td>
</tr>
<tr>
<td align="left" valign="top">pET28a-<italic>arcR</italic>-R</td>
<td align="left" valign="top">TCCTCTAGAGTCGACCTGCAGTACGTTAGACCTCATGTTCAAC</td>
<td align="left" valign="top"><italic>arcR</italic> in <italic>E. coli</italic></td>
</tr>
<tr>
<td align="left" valign="top">Q-16S rRNA-F</td>
<td align="left" valign="top">ACAAAGTGACAGGTGGTGCA</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-16S rRNA-R</td>
<td align="left" valign="top">GTTTGTCACCGGCAGTCAAC</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>perR</italic>-F</td>
<td align="left" valign="top">ACTCATCCAACAGCTGATG</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>perR</italic>-R</td>
<td align="left" valign="top">TCGAATCGACTTGATGAGTCTCC</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>katA</italic>-F</td>
<td align="left" valign="top">TAGACCAGTCCCAATTGCACCACC</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>katA</italic>-R</td>
<td align="left" valign="top">TCGCTTTACAGTACTAAATAGTTATTG</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>ahpC</italic>-F</td>
<td align="left" valign="top">AGGTTCTTGGAGCGTAGTATGC</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>ahpC</italic>-R</td>
<td align="left" valign="top">TGTGTACGAAGTGAGTATCAGTTG</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>ahpF</italic>-F</td>
<td align="left" valign="top">AAGAAACAGGTGTAACATTTGC</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>ahpF</italic>-R</td>
<td align="left" valign="top">TGCTTGAACGACATCAGGAC</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>dps</italic>-F</td>
<td align="left" valign="top">CGGTAGGAGGAAACCCTGTA</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>dps</italic>-R</td>
<td align="left" valign="top">TGATACATCATCGCCAGCAT</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>hmp</italic>-F</td>
<td align="left" valign="top">AAGGCTATATTGGCGCTGAA</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>hmp</italic>-R</td>
<td align="left" valign="top">TGCAACGCTTAGTCTTGGAA</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>norA</italic>-F</td>
<td align="left" valign="top">TTCACCAAGCCATCAAAAAG</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>norA</italic>-R</td>
<td align="left" valign="top">CTTGCCTTTCTCCAGCAATA</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>norB</italic>-F</td>
<td align="left" valign="top">TTGCAACGCTTTTAGGTTGG</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>norB</italic>-R</td>
<td align="left" valign="top">TACACCTAATTCTGATCC</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>srrA</italic>-F</td>
<td align="left" valign="top">GTCATTTAGCAGAACATGGG</td>
<td align="left" valign="top" rowspan="2">qRT-PCR</td>
</tr>
<tr>
<td align="left" valign="top">Q-<italic>srrA</italic>-R</td>
<td align="left" valign="top">ACAGGTCATACCTCCCACAC</td>
</tr>
<tr>
<td align="left" valign="top">E-<italic>arcR</italic>-F</td>
<td align="left" valign="top">ATCTTCCATATTTAGTCTCC</td>
<td align="left" valign="top" rowspan="2">EMSA</td>
</tr>
<tr>
<td align="left" valign="top">E-<italic>arcR</italic>-R</td>
<td align="left" valign="top">ACACCAGTTAACTTTTTGTCTTG</td>
</tr>
<tr>
<td align="left" valign="top">E-<italic>tetA</italic>-F</td>
<td align="left" valign="top">AGCGCGTGTTGTTATGTCGC</td>
<td align="left" valign="top" rowspan="2">EMSA</td>
</tr>
<tr>
<td align="left" valign="top">E-<italic>tetA</italic>-R</td>
<td align="left" valign="top">ACCTCCTTATTAGACAATGTG</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec4">
<title>Construction of knockout and complementary strains</title>
<p>To construct <italic>arcR</italic> knockout plasmid, the upstream and downstream homologous arm fragments were amplified from wild-type strain NCTC8325 and then ligated by overlap PCR. The obtained fragment was cloned into the pBTs plasmid digested with <italic>Eco</italic>R I and <italic>Hin</italic>d III. Ampicillin was used to screen the correct transformants. The pBTs derivative pBTs-<italic>arcR</italic> was electroporated into RN4220 for modification and transformed into NCTC8325 for allelic replacement as described (<xref ref-type="bibr" rid="ref14">Hu et al., 2015</xref>). PCR and sequencing were used to verify the mutation. For the construction of complementary plasmids, <italic>arcR</italic> and <italic>katA</italic> genes were amplified from NCTC8325, and the obtained fragments were ligated into pCN51 plasmid digested with <italic>Pst</italic> I. The derivates pCN51-<italic>arcR</italic> and pCN51-<italic>katA</italic> were transformed into RN4220 and subsequently electroporated into &#x0394;<italic>arcR</italic> mutant. Expression of <italic>arcR</italic> and <italic>katA</italic> was induced by 10&#x2009;&#x03BC;M CdCl<sub>2</sub> if necessary.</p>
</sec>
<sec id="sec5">
<title>Minimal inhibit concentration and survival assays</title>
<p>The MICs of <italic>S. aureus</italic> to a variety of antibiotics were determined in Mueller-Hinton Broth medium as described previously (<xref ref-type="bibr" rid="ref3">Borrero et al., 2014</xref>). For the determination of time-dependent bactericidal curves, overnight culture was diluted into fresh TSB medium at a ratio of 1:100 and incubated at 37&#x00B0;C and 220&#x2009;rpm until OD<sub>600</sub> reached 1.0. The MICs of ciprofloxacin, ofloxacin, norfloxacin, levofloxacin, moxifloxacin, and garenoxacin were 0.32, 0.25, 0.48, 0.19, 0.125, and 0.03&#x2009;&#x03BC;g/ml, respectively. Thiourea (150&#x2009;mM) was added when the strains grew to OD<sub>600</sub> 0.6. Samples were taken out at certain time points, diluted 10-fold, and colonies counted by dropping plate.</p>
</sec>
<sec id="sec6">
<title>H<sub>2</sub>O<sub>2</sub> susceptibility assay</title>
<p>The overnight cultures were diluted with fresh TSB medium to OD<sub>600</sub> 0.05 and then, H<sub>2</sub>O<sub>2</sub> at a final concentration of 0.4&#x2009;mM was added to the cultures as described previously (<xref ref-type="bibr" rid="ref25">Oogai et al., 2016</xref>). They were incubated at 37&#x00B0;C with 150&#x2009;rpm and 1&#x2009;ml aliquots were removed at the indicated times. The supernatant was removed by centrifugation and pellet was washed twice with sterile 1&#x2009;&#x00D7;&#x2009;PBS. The precipitates were diluted 10-fold and then dropped onto TSB plates. The plates were cultured overnight at 37&#x00B0;C, and colony counts were performed on the next day.</p>
</sec>
<sec id="sec7">
<title>Neutrophil extraction and ROS measurement</title>
<p>The whole blood of mice was collected with an anticoagulant tube, and neutrophils were extracted using a mouse peripheral blood neutrophil isolation kit (Solarbio, Beijing, China). The concentration of extracted cells was counted by cell counter. Measurement of ROS levels was determined as previously described with minor modifications (<xref ref-type="bibr" rid="ref31">Wu et al., 2009</xref>). Neutrophil cells were diluted to 10<sup>5</sup>/ml using warm Hanks&#x2019; balanced salt solution (HBSS) containing 100&#x2009;mM luminol and 1&#x2009;U/ml horseradish peroxidase. The diluted cell suspension was added to a 96-well plate at 200&#x2009;&#x03BC;l/well, and the reaction was performed at 37&#x00B0;C for 10&#x2009;min. The bacterial strains were added at a multiplicity of infection (MOI) of 5. At the same time, 10<sup>6</sup> cells were removed and infected with an MOI of 10. The reaction was carried out in a cell incubator at 37&#x00B0;C, and 20&#x2009;&#x03BC;l reactant was removed every hour for dilution and dropping plate counting, to which 100&#x2009;mM NAC was added if necessary.</p>
</sec>
<sec id="sec8">
<title>RNA extraction, reverse transcription, and quantitative real-time PCR</title>
<p>When the bacteria were cultured in TSB medium to OD<sub>600</sub> 1.0, they were treated in PBS containing 0.4&#x2009;mM H<sub>2</sub>O<sub>2</sub> for 10&#x2009;min and collected by centrifugation. Total RNA was extracted using RNAprep Pure Cell/Bacteria Kit (Tiangen Biotech, Beijing, China). Then, cDNA was synthesized with 1&#x2009;&#x03BC;g RNA and PrimeScript&#x2122; IV 1st strand cDNA Synthesis Mix (Takara, Dalian, China). For the qRT-PCR, cDNA was mixed with specific primers (<xref rid="tab2" ref-type="table">Table 2</xref>) and chamQ universal SYBR quantitative RT-PCR master mix (Vazyme, Nanjing, China). 16S rRNA gene was used as internal controls.</p>
</sec>
<sec id="sec9">
<title>Catalase activity assay</title>
<p>Bacteria were cultured to OD<sub>600</sub> 1.0 using TSB medium, and 1&#x2009;ml of culture was collected by centrifugation and washed twice with PBS. The cultures were incubated in PBS with or without 0.4&#x2009;mM H<sub>2</sub>O<sub>2</sub> for 30&#x2009;min. The reaction samples were collected by centrifugation, washed twice with PBS, and broken by Ultrasonic Cell Disruptor (Xinzhi, Ningbo, China). Catalase activity was detected using a catalase assay kit (Beyotime, Shanghai, China).</p>
</sec>
<sec id="sec10">
<title>ArcR protein expression and purification</title>
<p>For the construction of ArcR expression plasmid, the <italic>arcR</italic> gene fragment was amplified from NCTC8325 genome and the PCR product was ligated with pET28a digested with <italic>Eco</italic>RI. Kanamycin was used to screen the correct transformants. PCR and sequencing were used for verification to obtain the correct expression of pET28A-his6-ArcR. The correctly constructed pET28a-His6-ArcR plasmid was transferred into <italic>E. coli</italic> BL21(DE3). The transformers were grown in LB medium containing 50&#x2009;&#x03BC;g/ml kanamycin at 37&#x00B0;C until OD<sub>600</sub> reached 0.6 and were induced with 0.5&#x2009;mM IPTG at 37&#x00B0;C for 4&#x2009;h. The cells were harvested and lysed by sonication with lysis buffer (25&#x2009;mM HEPES, 5&#x2009;mM &#x03B2;-mercaptoethanol, 500&#x2009;mM NaCl, and 10% glycerol, pH 7.8). The His-tagged fusion proteins were purified in nickel nitrogen triacetate agarose solution (Qiagen, Beijing, China). The bounding protein was eluted by elution buffer (25&#x2009;mM HEPES, 5&#x2009;mM &#x03B2;-mercaptoethanol, 500&#x2009;mM NaCl, 10% glycerol, and 500&#x2009;mM imidazole, pH 7.8). Target protein was stored at &#x2212;80&#x00B0;C until use. The concentration of purified proteins was determined by SDS-PAGE and bicinchoninic acid as the standard protein.</p>
</sec>
<sec id="sec11">
<title>Electrophoretic mobility shift assay</title>
<p>EMSA was performed as previously described with minor modifications (<xref ref-type="bibr" rid="ref10">Hellman and Fried, 2007</xref>). We used NCTC8325 as the template to amplify <italic>katA</italic> promoter region DNA fragment. The 30&#x2009;ng DNA fragment was incubated with 0, 100, 200, and 400&#x2009;ng purified ArcR in binding buffer (25&#x2009;mM HEPES, 1&#x2009;mM dithiothreitol, 200&#x2009;mM NaCl, and 10% glycerol, pH 7.8) at 37&#x00B0;C for 30&#x2009;min. The 8% polyacrylamide gel was pre-electrophoresed in 1&#x00D7; Tris-borate-EDTA buffer (0.044&#x2009;M Tris, 0.044&#x2009;M boric acid, and 0.001&#x2009;M EDTA, pH 8.0) for 1&#x2009;h to remove impurities. After adding the sample, electrophoresis was performed for 1&#x2009;h 40&#x2009;min on ice. At the end of the electrophoresis, the glue was stained with 0.5&#x2009;&#x03BC;g/ml ethidium bromide. Imaging was performed using a gel imager (Bio-Rad, Hercules, CA, USA).</p>
</sec>
</sec>
<sec id="sec12" sec-type="results">
<title>Results</title>
<sec id="sec13">
<title>ArcR is involved in tolerance of <italic>Staphylococcus aureus</italic> to fluoroquinolone antibiotics</title>
<p>To understand whether ArcR affected antibiotic resistance of <italic>S. aureus</italic>, the MICs of &#x0394;<italic>arcR</italic> mutants to ciprofloxacin, ofloxacin, linezolid, tetracycline, vancomycin, erythromycin, chloramphenicol, norfloxacin, levofloxacin, moxifloxacin, garenoxacin, and daptomycin were determined. Wild-type NCTC8325 and &#x0394;<italic>arcR</italic> mutant displayed similar levels of resistance (MICs) to the above antibiotics (<xref rid="tab3" ref-type="table">Table 3</xref>). However, following treatment with 0.32&#x2009;&#x03BC;g/ml ciprofloxacin, 0.5&#x2009;&#x03BC;g/ml ofloxacin, 0.5&#x2009;&#x03BC;g/ml norfloxacin, 0.5&#x2009;&#x03BC;g/ml levofloxacin, 0.2&#x2009;&#x03BC;g/ml moxifloxacin, or 0.06&#x2009;&#x03BC;g/ml garenoxacin, the survival rate of &#x0394;<italic>arcR</italic> mutant was approximately 342-, 158-, 74-, 20-, 93-, or 87-fold lower than that of wild-type NCTC8325 strain after 10&#x2009;h sterilization (<xref rid="fig1" ref-type="fig">Figures 1A</xref>&#x2013;<xref rid="fig1" ref-type="fig">F</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>MICs of <italic>S. aureus</italic> to antibiotics.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2">Strain</th>
<th align="center" valign="middle" colspan="6">MIC (&#x03BC;g/ml)</th>
</tr>
<tr>
<th align="center" valign="middle">CIP</th>
<th align="center" valign="middle">OFX</th>
<th align="center" valign="middle">TCY</th>
<th align="center" valign="middle">VAN</th>
<th align="center" valign="middle">ERY</th>
<th align="center" valign="middle">CHL</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">WT</td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">0.63</td>
</tr>
<tr>
<td align="left" valign="top">&#x0394;<italic>arcR</italic></td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">0.63</td>
</tr>
<tr>
<td align="left" valign="top">&#x0394;<italic>arcR/arcR</italic></td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.63</td>
<td align="center" valign="top">0.25</td>
<td align="center" valign="top">0.63</td>
</tr>
<tr>
<td/>
<td align="center" valign="top">NOR</td>
<td align="center" valign="top">lEV</td>
<td align="center" valign="top">MFX</td>
<td align="center" valign="top">GRN</td>
<td align="center" valign="top">DAP</td>
<td align="center" valign="top">LZN</td>
</tr>
<tr>
<td align="left" valign="top">WT</td>
<td align="center" valign="top">0.48</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top">0.125</td>
<td align="center" valign="top">0.03</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.13</td>
</tr>
<tr>
<td align="left" valign="top">&#x0394;<italic>arcR</italic></td>
<td align="center" valign="top">0.48</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top">0.125</td>
<td align="center" valign="top">0.03</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.13</td>
</tr>
<tr>
<td align="left" valign="top">&#x0394;<italic>arcR/arcR</italic></td>
<td align="center" valign="top">0.48</td>
<td align="center" valign="top">0.19</td>
<td align="center" valign="top">0.125</td>
<td align="center" valign="top">0.03</td>
<td align="center" valign="top">1.25</td>
<td align="center" valign="top">0.13</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Roles of ArcR in bacterial resistance to fluoroquinolone antibiotics. Bacteria at OD<sub>600</sub> 1.0 were treated with <bold>(A)</bold> 0.32&#x2009;&#x03BC;g/ml ciprofloxacin, <bold>(B)</bold> 0.5&#x2009;&#x03BC;g/ml ofloxacin, <bold>(C)</bold> 0.5&#x2009;&#x03BC;g/ml norfloxacin, <bold>(D)</bold> 0.5&#x2009;&#x03BC;g/ml levofloxacin, <bold>(E)</bold> 0.2&#x2009;&#x03BC;g/ml moxifloxacin, or <bold>(F)</bold> 0.06&#x2009;&#x03BC;g/ml garenoxacin in TSB at 37&#x00B0;C with agitation. Bacteria were collected at indicated times, and CFUs were determined by serial dilution and plating. &#x0394;<italic>arcR</italic>/<italic>arcR</italic> represented the complementary strain, pCN51-<italic>arcR</italic> in &#x0394;<italic>arcR</italic> mutant. Error bars represent standard deviations. The data represent results from three independent experiments. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, by Student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g001.tif"/>
</fig>
</sec>
<sec id="sec14">
<title>Defective oxidative stress response leads to increased susceptibility to fluoroquinolone antibiotics in &#x0394;<italic>arcR</italic> mutant</title>
<p>The tolerance of <italic>S. aureus</italic> to fluoroquinolones is usually associated with mutations of topoisomerase II genes, including <italic>gyrA</italic> and <italic>gyrB</italic>, and high expression of NorA, NorB, NorC, and SdrM belonging to MFS superfamily efflux pump (<xref ref-type="bibr" rid="ref21">Lowy, 2003</xref>; <xref ref-type="bibr" rid="ref5">Ding et al., 2008</xref>; <xref ref-type="bibr" rid="ref33">Xu et al., 2011</xref>). Expression of <italic>norA</italic>, <italic>norB</italic>, <italic>norC</italic>, and <italic>sdrM</italic> was detected in &#x0394;<italic>arcR</italic> mutant, and there was no significant difference compared with the wild-type strain (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figures 1A&#x2013;D</xref>). These results suggest that ArcR influenced the resistance of <italic>S. aureus</italic> against fluoroquinolone antibiotics through other mechanisms.</p>
<p>It was reported that ROS was involved in the bactericidal process of aminoglycoside, &#x03B2;-lactam, and fluoroquinolone antibiotics (<xref ref-type="bibr" rid="ref18">Kohanski et al., 2007</xref>). To determine the role of ROS in the increased sensitivity of &#x0394;<italic>arcR</italic> mutant to fluoroquinolones, thiourea that neutralize intracellular ROS was added into the medium when killing curves were detected. Thiourea supplementation increased the survival rate of the &#x0394;<italic>arcR</italic> mutant strain to a level similar to that of the wild type when treated with the same concentration of antibiotics (<xref rid="fig2" ref-type="fig">Figures 2A</xref>,<xref rid="fig2" ref-type="fig">B</xref>). These results suggest that a defective oxidative stress response leads to increased sensitivity to fluoroquinolone antibiotics in &#x0394;<italic>arcR</italic> mutant.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Effects of hydroxyl radical scavenger on bacterial resistance to fluoroquinolone antibiotics. Bacteria were treated with <bold>(A)</bold> 0.32&#x2009;&#x03BC;g/ml ciprofloxacin or <bold>(B)</bold> 0.5&#x2009;&#x03BC;g/ml ofloxacin in the presence or absence of 150&#x2009;mM thiourea in TSB at 37&#x00B0;C with agitation. At the indicated times, the live bacterial counts were determined by serial dilution and plating. Error bars represent standard deviations. The data represent results from three independent experiments. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001 by Student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g002.tif"/>
</fig>
</sec>
<sec id="sec15">
<title>ArcR is involved in bacterial tolerance to oxidative stress</title>
<p>The bacterial response to oxidative stress is a manifestation of virulence, which can help bacteria to resist ROS produced by phagocytes and enhance their infectivity. Activated neutrophils produce O<sub>2</sub>&#x2022;<sup>&#x2212;</sup>, H<sub>2</sub>O<sub>2</sub>, nitric oxide (NO), and hypochlorite (HOCl), which kill invading pathogenic bacteria through oxidative burst (<xref ref-type="bibr" rid="ref8">Forman et al., 2002</xref>; <xref ref-type="bibr" rid="ref29">van der Veen et al., 2009</xref>). To understand the role of ArcR in the bacterial oxidative stress response, bacteria were incubated with neutrophils. The wild type and &#x0394;<italic>arcR</italic> mutant could introduce the same level ROS produced by neutrophils when they were incubated with neutrophils (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 2</xref>). However, the survival rate of &#x0394;<italic>arcR</italic> mutant was significantly lower than that of wild-type strain when they were treated with neutrophils (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). The presence of ROS-neutralizing N-acetylcysteine (NAC) increased the survival rate of &#x0394;<italic>arcR</italic> mutant after incubation with neutrophils (<xref rid="fig3" ref-type="fig">Figure 3B</xref>). We used H<sub>2</sub>O<sub>2</sub> to verify the role of ArcR in bacterial tolerance to oxidative stress, and the &#x0394;<italic>arcR</italic> mutant showed higher sensitivity to H<sub>2</sub>O<sub>2</sub> than wild-type strain (<xref rid="fig3" ref-type="fig">Figure 3C</xref>). These results suggest that ArcR contributes to bacterial resistance to oxidative stress.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Roles of ArcR in bacterial tolerance to neutrophils and H<sub>2</sub>O<sub>2</sub>. <bold>(A)</bold> Bacteria were incubated with mouse neutrophils at an MOI of 5 in HBSS or <bold>(B)</bold> HBSS containing 80&#x2009;mM NAC. Live bacterial counts were determined every hour for 3&#x2009;h. <bold>(C)</bold> Bacteria were treated with 0.4&#x2009;mM H<sub>2</sub>O<sub>2</sub> for 12&#x2009;h in TSB at 37&#x00B0;C. Live bacterial counts were determined by serial dilution and plating. The survival rate was calculated as the number of CFUs of each strain after individual treatment divided by the number of CFUs in the corresponding sample before treatment. The data represent results from three independent experiments. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, by Student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g003.tif"/>
</fig>
</sec>
<sec id="sec16">
<title>ArcR participates in regulation of oxidative stress resistance genes</title>
<p>The increased sensitivity to ROS suggested that the expression of genes involved in ROS response might be reduced in &#x0394;<italic>arcR</italic> mutant. PerR is a major global regulator of H<sub>2</sub>O<sub>2</sub> response, which is a repressor of peroxide reaction (<xref ref-type="bibr" rid="ref6">Dubbs and Mongkolsuk, 2012</xref>). The expression of PerR was not significantly altered in &#x0394;<italic>arcR</italic> mutant (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). We measured the expression of other ROS resistance genes. In the presence or absence of H<sub>2</sub>O<sub>2</sub>, mRNA levels of <italic>katA</italic>, which encodes primary catalase, were approximately fourfold lower in the &#x0394;<italic>arcR</italic> mutant than in the wild-type strain (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). Whereas, the mRNA levels of <italic>ahpC</italic>, <italic>ahpF</italic>, <italic>dps</italic>, and <italic>hmp</italic> were similar between the wild-type and &#x0394;<italic>arcR</italic> mutant (<xref rid="fig4" ref-type="fig">Figures 4C</xref>&#x2013;<xref rid="fig4" ref-type="fig">F</xref>). Total catalase activity was lower in &#x0394;<italic>arcR</italic> mutant than that in wild-type strains when treated with or without H<sub>2</sub>O<sub>2</sub>, which consistent with the change of <italic>katA</italic> mRNA levels (<xref rid="fig4" ref-type="fig">Figure 4G</xref>). Complement with <italic>arcR</italic> or <italic>katA</italic> in &#x0394;<italic>arcR</italic> mutant restored the catalase to wild-type level (<xref rid="fig4" ref-type="fig">Figure 4G</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Expression of oxidative stress responsive genes. Bacteria were treated with or without 0.4&#x2009;mM H<sub>2</sub>O<sub>2</sub> for 10&#x2009;min in PBS. The mRNA levels of <italic>perR</italic> <bold>(A)</bold>, <italic>katA</italic> <bold>(B)</bold>, <italic>ahpC</italic> <bold>(C)</bold>, <italic>ahpF</italic> <bold>(D)</bold>, <italic>dpS</italic> <bold>(E)</bold>, and <italic>hmp</italic> <bold>(F)</bold> were determined by real-time PCR. The 16S rRNA gene was used as an internal control. <bold>(G)</bold> Bacteria were lysed by sonication, and catalase activity was determined with a catalase assay kit. The data represent results from three independent experiments. ns, not significant. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, by Student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g004.tif"/>
</fig>
<p>Overexpression of <italic>katA</italic> in &#x0394;<italic>arcR</italic> mutant strain restored bacterial tolerance to neutrophils, H<sub>2</sub>O<sub>2</sub>, ofloxacin, and ciprofloxacin (<xref rid="fig5" ref-type="fig">Figures 5A</xref>&#x2013;<xref rid="fig5" ref-type="fig">D</xref>). These results confirmed that downregulation of <italic>katA</italic> expression was responsible for bacterial susceptibility to H<sub>2</sub>O<sub>2</sub> which increased Fenton reaction and OH&#x2022; production and finally resulted in decreased tolerance to fluoroquinolone antibiotics.</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Overexpression of <italic>katA</italic> restored resistance of &#x0394;<italic>arcR</italic> mutant against antibiotics and oxidative stress. <bold>(A)</bold> Bacteria were incubated with mouse neutrophils at MOI 5 in HBSS for 3&#x2009;h. <bold>(B)</bold> Bacteria were treated with 0.4&#x2009;mM H<sub>2</sub>O<sub>2</sub> for 12&#x2009;h in TSB at 37&#x00B0;C. (C and D) Bacteria were treated with <bold>(C)</bold> 0.32&#x2009;&#x03BC;g/ml ciprofloxacin or <bold>(D)</bold> 0.5&#x2009;&#x03BC;g/ml ofloxacin for 10&#x2009;h in TSB with agitation. Live counts were determined by plating. &#x0394;<italic>arcR</italic>/<italic>katA</italic> represented the <italic>katA</italic> overexpression strain, pCN51-<italic>katA</italic> in &#x0394;<italic>arcR</italic> mutant. The data represent results from three independent experiments. ns, not significant. &#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05, &#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.01, and &#x002A;&#x002A;&#x002A;<italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, by Student&#x2019;s <italic>t</italic>-test.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g005.tif"/>
</fig>
</sec>
<sec id="sec17">
<title>ArcR promotes expression of <italic>katA</italic> at the transcriptional level by directly binding to the <italic>katA</italic> promoter region</title>
<p>The ArcR regulator of <italic>S. aureus</italic> contains two domains that are characteristic of members of the Crp family of regulatory proteins. Structural prediction showed that the N terminus of ArcR had a circular nucleotide binding domain, and the C terminus contained a highly conserved helix-turn-helix DNA-binding domain. To explore how ArcR regulated <italic>katA</italic> transcription, we used pET 28a to express ArcR protein in <italic>E. coli</italic> BL21. Electrophoretic mobility shift assay (EMSA) was performed to detect the binding of ArcR to 244-bp DNA in the promoter region of <italic>katA</italic>. The amount of free DNA gradually decreased as the amount of ArcR protein increased (<xref rid="fig6" ref-type="fig">Figure 6A</xref>). The specificity of binding was reflected in the fact that DNA mobility was not affected when an unrelated His-tagged TetR protein was used. It also did not bind to 267-bp DNA of <italic>tetA</italic> promoter region (<xref rid="fig6" ref-type="fig">Figures 6B</xref>,<xref rid="fig6" ref-type="fig">C</xref>). These results suggested that the binding of ArcR to the <italic>katA</italic> promoter region was specific.</p>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p>ArcR promotes expression of <italic>katA</italic> by directly binding to its promoter region. Interaction between ArcR and <italic>katA</italic> promoter region was examined by EMSA. ArcR was incubated with <italic>katA</italic> promoter region <bold>(A)</bold>, ArcR was incubated with <italic>tetA</italic> promoter region <bold>(B)</bold>, and TetR was incubated with <italic>katA</italic> promoter region <bold>(C)</bold> at 37&#x00B0;C for 30&#x2009;min. The mixtures were electrophoresed on agarose gels and the bands were visualized under UV light after ethidium bromide staining. The data represent results from three independent experiments.</p>
</caption>
<graphic xlink:href="fmicb-14-1106340-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="sec18" sec-type="discussions">
<title>Discussion</title>
<p>We found that ArcR controlled the resistance of bacteria to fluoroquinolones by modulating catalase KatA. Enzymes involved in the oxidative stress response have been shown to contribute to antibiotic resistance. KatA and superoxide dismutase are involved in bacterial antibiotic resistance. In <italic>Enterococcus faecalis</italic>, the absence of superoxide dismutase gene <italic>sodA</italic> reduced the bacterial tolerance to vancomycin and penicillin (<xref ref-type="bibr" rid="ref2">Bizzini et al., 2009</xref>). In <italic>Acinetobacter baumannii</italic>, the <italic>sod2343</italic> mutant strains were more susceptible to colistin and tetracycline (<xref ref-type="bibr" rid="ref9">Heindorf et al., 2014</xref>). In <italic>Pseudomonas aeruginosa</italic>, <italic>katA</italic> plays an important role in bacterial tolerance to aminoglycoside and &#x03B2;-lactam antibiotics (<xref ref-type="bibr" rid="ref32">Xia et al., 2019</xref>). KatA is the major catalase in <italic>S. aureus</italic>. Here, we demonstrated that KatA was involved in bacterial tolerance to oxidative stress and subsequent tolerance to fluoroquinolone antibiotics. Additionally, KatA affected the survival of <italic>S. aureus</italic> at low temperature (<xref ref-type="bibr" rid="ref23">Masmoudi et al., 2010</xref>; <xref ref-type="bibr" rid="ref28">Suo et al., 2022</xref>).</p>
<p>PerR functions as a major repressed regulator of the response to H<sub>2</sub>O<sub>2</sub> in <italic>S. aureus</italic>, which replaces OxyR in many Gram-positive bacteria (<xref ref-type="bibr" rid="ref24">Mongkolsuk and Helmann, 2002</xref>; <xref ref-type="bibr" rid="ref6">Dubbs and Mongkolsuk, 2012</xref>). In <italic>S. aureus</italic>, Fur is a regulator interacting with PerR, which participates in the oxidative stress response by positively regulating catalase and iron homeostasis (<xref ref-type="bibr" rid="ref12">Horsburgh et al., 2001</xref>). Sigma B controls the general stress response, and there are sigma B recognition sites in the <italic>katA</italic> promoter region, which in some cases regulate <italic>katA</italic> expression (<xref ref-type="bibr" rid="ref11">Horsburgh et al., 2002</xref>). ppGpp regulates <italic>katA</italic> expression in a PerR-independent manner (<xref ref-type="bibr" rid="ref13">Horvatek et al., 2020</xref>). The <italic>srrAB</italic> two-component regulatory system can inhibit expression of <italic>katA</italic>, and the <italic>srrA</italic> promoter region is predicted by bioinformatics to contain an ArcR binding site (<xref ref-type="bibr" rid="ref22">Makhlin et al., 2007</xref>; <xref ref-type="bibr" rid="ref25">Oogai et al., 2016</xref>). To determine whether ArcR also regulated expression of <italic>katA</italic> by repressing <italic>srrAB</italic>, we detected expression of <italic>srrAB</italic> in &#x0394;<italic>arcR</italic> mutant by quantitative RT-PCR and found that it was not significantly different from that in the wild-type strain. This indicates that ArcR directly regulates expression of <italic>katA</italic>, and this process is independent of <italic>srrAB</italic>.</p>
<p>Glucose in combination with aminoglycosides could be used to treat the biofilms of <italic>E. coli</italic> and <italic>S. aureus</italic>. Glucose catabolism generated NADH and then NADH was oxidized in the electron transport chain, which, in turn, contributed to PMF. The elevated PMF facilitated the uptake of aminoglycoside antibiotics (<xref ref-type="bibr" rid="ref1">Allison et al., 2011</xref>; <xref ref-type="bibr" rid="ref26">Peng et al., 2015</xref>). Cyclic lipopeptide resistance can also be affected by glucose, which induces bacterial resistance to polymyxin B by enhancing glycolytic flux to maintain intracellular ATP levels in PB-treated bacteria. Similar results were observed in <italic>S. aureus</italic>, where glucose enhanced daptomycin resistance (<xref ref-type="bibr" rid="ref35">Yu et al., 2019</xref>). In <italic>S. aureus</italic>, glucose could inhibit the expression of <italic>arcR</italic>. Meanwhile, <italic>arcR</italic> affect the response of <italic>S. aureus</italic> to ROS and then affect the sensitivity to fluoroquinolone antibiotics. Therefore, glucose most likely influences the tolerance of <italic>S. aureus</italic> to fluoroquinolone antibiotics through ArcR. This study may add to our understanding on the role of carbon metabolism in bacterial susceptibility to antibiotics.</p>
</sec>
<sec id="sec19" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="sec20">
<title>Author contributions</title>
<p>TF, ZF, and YL designed the experiments, performed the experiments, and wrote the manuscript. JY designed the experiments and revised the manuscript. All authors performed the experiments, analyzed the results, or revised the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec21" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by grants from the National Natural Science Foundation for Key Programs of China Grants (82130065), National Natural Science Foundation of China (32170201 and 82002191), Beijing Natural Science Foundation (7222014), FENG foundation (FFBR 202103), the Research Foundation of Capital Institute of Pediatrics (CXYJ-2021-04), Public service development and reform pilot project of the Beijing Medical Research Institute (BMR2019-11), and Postdoctoral Research Fund of Chaoyang District, Beijing, China in 2021.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>We thank Cathel Kerr from Edanz (<ext-link xlink:href="https://jp.edanz.com/ac" ext-link-type="uri">https://jp.edanz.com/ac</ext-link>) for editing a draft of this manuscript.</p>
</ack>
<sec id="sec23" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2023.1106340/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2023.1106340/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.doc" id="SM1" mimetype="application/msword" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname> <given-names>K. R.</given-names></name> <name><surname>Brynildsen</surname> <given-names>M. P.</given-names></name> <name><surname>Collins</surname> <given-names>J. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Metabolite-enabled eradication of bacterial persisters by aminoglycosides</article-title>. <source>Nature</source> <volume>473</volume>, <fpage>216</fpage>&#x2013;<lpage>220</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature10069</pub-id>, PMID: <pub-id pub-id-type="pmid">21562562</pub-id></citation></ref>
<ref id="ref001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname> <given-names>T.</given-names></name> <name><surname>Schneewind</surname> <given-names>O.</given-names></name></person-group> (<year>2006</year>). <article-title>Allelic replacement in Staphylococcus aureus with inducible counter-selection</article-title>. <source>Plasmid</source> <volume>55</volume>, <fpage>58</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.plasmid.2005.05.005</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bizzini</surname> <given-names>A.</given-names></name> <name><surname>Zhao</surname> <given-names>C.</given-names></name> <name><surname>Auffray</surname> <given-names>Y.</given-names></name> <name><surname>Hartke</surname> <given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>The <italic>Enterococcus faecalis</italic> superoxide dismutase is essential for its tolerance to vancomycin and penicillin</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>64</volume>, <fpage>1196</fpage>&#x2013;<lpage>1202</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkp369</pub-id>, PMID: <pub-id pub-id-type="pmid">19828491</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borrero</surname> <given-names>N. V.</given-names></name> <name><surname>Bai</surname> <given-names>F.</given-names></name> <name><surname>Perez</surname> <given-names>C.</given-names></name> <name><surname>Duong</surname> <given-names>B. Q.</given-names></name> <name><surname>Rocca</surname> <given-names>J. R.</given-names></name> <name><surname>Jin</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic></article-title>. <source>Org. Biomol. Chem.</source> <volume>12</volume>, <fpage>881</fpage>&#x2013;<lpage>886</lpage>. doi: <pub-id pub-id-type="doi">10.1039/c3ob42416b</pub-id>, PMID: <pub-id pub-id-type="pmid">24389824</pub-id></citation></ref>
<ref id="ref002"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charpentier</surname> <given-names>E.</given-names></name> <name><surname>Anton</surname> <given-names>A. I.</given-names></name> <name><surname>Barry</surname> <given-names>P.</given-names></name> <name><surname>Fang</surname> <given-names>Y.</given-names></name> <name><surname>Novick</surname> <given-names>R. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Novel cassette-based shuttle vector system for gram-positive bacteria</article-title>. <source>Appl Environ Microbiol</source> <volume>70</volume>, <fpage>6076</fpage>&#x2013;<lpage>6085</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aem.70.10.6076-6085.2004</pub-id>, PMID: <pub-id pub-id-type="pmid">19622015</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname> <given-names>G. Y. C.</given-names></name> <name><surname>Bae</surname> <given-names>J. S.</given-names></name> <name><surname>Otto</surname> <given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Pathogenicity and virulence of <italic>Staphylococcus aureus</italic></article-title>. <source>Virulence</source> <volume>12</volume>, <fpage>547</fpage>&#x2013;<lpage>569</lpage>. doi: <pub-id pub-id-type="doi">10.1080/21505594.2021.1878688</pub-id>, PMID: <pub-id pub-id-type="pmid">33522395</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>Y.</given-names></name> <name><surname>Onodera</surname> <given-names>Y.</given-names></name> <name><surname>Lee</surname> <given-names>J. C.</given-names></name> <name><surname>Hooper</surname> <given-names>D. C.</given-names></name></person-group> (<year>2008</year>). <article-title>NorB, an efflux pump in <italic>Staphylococcus aureus</italic> strain MW2, contributes to bacterial fitness in abscesses</article-title>. <source>J. Bacteriol.</source> <volume>190</volume>, <fpage>7123</fpage>&#x2013;<lpage>7129</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00655-08</pub-id>, PMID: <pub-id pub-id-type="pmid">18723624</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubbs</surname> <given-names>J. M.</given-names></name> <name><surname>Mongkolsuk</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Peroxide-sensing transcriptional regulators in bacteria</article-title>. <source>J. Bacteriol.</source> <volume>194</volume>, <fpage>5495</fpage>&#x2013;<lpage>5503</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00304-12</pub-id>, PMID: <pub-id pub-id-type="pmid">22797754</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname> <given-names>D. J.</given-names></name> <name><surname>Kohanski</surname> <given-names>M. A.</given-names></name> <name><surname>Hayete</surname> <given-names>B.</given-names></name> <name><surname>Collins</surname> <given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Gyrase inhibitors induce an oxidative damage cellular death pathway in <italic>Escherichia coli</italic></article-title>. <source>Mol. Syst. Biol.</source> <volume>3</volume>:<fpage>91</fpage>. doi: <pub-id pub-id-type="doi">10.1038/msb4100135</pub-id>, PMID: <pub-id pub-id-type="pmid">17353933</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Forman</surname> <given-names>H. J.</given-names></name> <name><surname>Torres</surname> <given-names>M.</given-names></name> <name><surname>Fukuto</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Redox signaling</article-title>. <source>Mol. Cell. Biochem.</source> <volume>234/235</volume>, <fpage>49</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1023/A:1015913229650</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heindorf</surname> <given-names>M.</given-names></name> <name><surname>Kadari</surname> <given-names>M.</given-names></name> <name><surname>Heider</surname> <given-names>C.</given-names></name> <name><surname>Skiebe</surname> <given-names>E.</given-names></name> <name><surname>Wilharm</surname> <given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Impact of <italic>Acinetobacter baumannii</italic> superoxide dismutase on motility, virulence, oxidative stress resistance and susceptibility to antibiotics</article-title>. <source>PLoS One</source> <volume>9</volume>:<fpage>e101033</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0101033</pub-id>, PMID: <pub-id pub-id-type="pmid">25000585</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hellman</surname> <given-names>L. M.</given-names></name> <name><surname>Fried</surname> <given-names>M. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions</article-title>. <source>Nat. Protoc.</source> <volume>2</volume>, <fpage>1849</fpage>&#x2013;<lpage>1861</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nprot.2007.249</pub-id>, PMID: <pub-id pub-id-type="pmid">17703195</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horsburgh</surname> <given-names>M. J.</given-names></name> <name><surname>Aish</surname> <given-names>J. L.</given-names></name> <name><surname>White</surname> <given-names>I. J.</given-names></name> <name><surname>Shaw</surname> <given-names>L.</given-names></name> <name><surname>Lithgow</surname> <given-names>J. K.</given-names></name> <name><surname>Foster</surname> <given-names>S. J.</given-names></name></person-group> (<year>2002</year>). <article-title>sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from <italic>Staphylococcus aureus</italic> 8325-4</article-title>. <source>J. Bacteriol.</source> <volume>184</volume>, <fpage>5457</fpage>&#x2013;<lpage>5467</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.184.19.5457-5467.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12218034</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horsburgh</surname> <given-names>M. J.</given-names></name> <name><surname>Ingham</surname> <given-names>E.</given-names></name> <name><surname>Foster</surname> <given-names>S. J.</given-names></name></person-group> (<year>2001</year>). <article-title>In <italic>Staphylococcus aureus</italic>, fur is an interactive regulator with PerR, contributes to virulence, and is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis</article-title>. <source>J. Bacteriol.</source> <volume>183</volume>, <fpage>468</fpage>&#x2013;<lpage>475</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.183.2.468-475.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11133939</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horvatek</surname> <given-names>P.</given-names></name> <name><surname>Salzer</surname> <given-names>A.</given-names></name> <name><surname>Hanna</surname> <given-names>A. M. F.</given-names></name> <name><surname>Gratani</surname> <given-names>F. L.</given-names></name> <name><surname>Keinh&#x00F6;rster</surname> <given-names>D.</given-names></name> <name><surname>Korn</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Inducible expression of (pp)pGpp synthetases in <italic>Staphylococcus aureus</italic> is associated with activation of stress response genes</article-title>. <source>PLoS Genet.</source> <volume>16</volume>:<fpage>e1009282</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pgen.1009282</pub-id>, PMID: <pub-id pub-id-type="pmid">33378356</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>J.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Sun</surname> <given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant <italic>Staphylococcus aureus</italic> strain MW2</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>1352</fpage>&#x2013;<lpage>1355</lpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.04290-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25451044</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname> <given-names>J. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Pathways of oxidative damage</article-title>. <source>Annu. Rev. Microbiol.</source> <volume>57</volume>, <fpage>395</fpage>&#x2013;<lpage>418</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.micro.57.030502.090938</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname> <given-names>J. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Cellular defenses against superoxide and hydrogen peroxide</article-title>. <source>Annu. Rev. Biochem.</source> <volume>77</volume>, <fpage>755</fpage>&#x2013;<lpage>776</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.biochem.77.061606.161055</pub-id>, PMID: <pub-id pub-id-type="pmid">18173371</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imlay</surname> <given-names>J. A.</given-names></name> <name><surname>Fridovich</surname> <given-names>I.</given-names></name></person-group> (<year>1991</year>). <article-title>Assay of metabolic superoxide production in <italic>Escherichia coli</italic></article-title>. <source>J. Biol. Chem.</source> <volume>266</volume>, <fpage>6957</fpage>&#x2013;<lpage>6965</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0021-9258(20)89596-9</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kohanski</surname> <given-names>M. A.</given-names></name> <name><surname>Dwyer</surname> <given-names>D. J.</given-names></name> <name><surname>Hayete</surname> <given-names>B.</given-names></name> <name><surname>Lawrence</surname> <given-names>C. A.</given-names></name> <name><surname>Collins</surname> <given-names>J. J.</given-names></name></person-group> (<year>2007</year>). <article-title>A common mechanism of cellular death induced by bactericidal antibiotics</article-title>. <source>Cells</source> <volume>130</volume>, <fpage>797</fpage>&#x2013;<lpage>810</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2007.06.049</pub-id>, PMID: <pub-id pub-id-type="pmid">17803904</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x00F6;rner</surname> <given-names>H.</given-names></name> <name><surname>Sofia</surname> <given-names>H. J.</given-names></name> <name><surname>Zumft</surname> <given-names>W. G.</given-names></name></person-group> (<year>2003</year>). <article-title>Phylogeny of the bacterial superfamily of Crp-Fnr transcription regulators: exploiting the metabolic spectrum by controlling alternative gene programs</article-title>. <source>FEMS Microbiol. Rev.</source> <volume>27</volume>, <fpage>559</fpage>&#x2013;<lpage>592</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0168-6445(03)00066-4</pub-id>, PMID: <pub-id pub-id-type="pmid">14638413</pub-id></citation></ref>
<ref id="ref003"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kreiswirth</surname> <given-names>B. N.</given-names></name> <name><surname>L&#x00F6;fdahl</surname> <given-names>S.</given-names></name> <name><surname>Betley</surname> <given-names>M. J.</given-names></name> <name><surname>O&#x2019;Reilly</surname> <given-names>M.</given-names></name> <name><surname>Schlievert</surname> <given-names>P. M.</given-names></name> <name><surname>Bergdoll</surname> <given-names>M. S.</given-names></name> <etal/></person-group> (<year>1983</year>). <article-title>The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage</article-title>. <source>Nature</source> <volume>305</volume>, <fpage>709</fpage>&#x2013;<lpage>712</lpage>. doi: <pub-id pub-id-type="doi">10.1038/305709a0</pub-id>, PMID: <pub-id pub-id-type="pmid">14638413</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname> <given-names>S. B.</given-names></name> <name><surname>Marshall</surname> <given-names>B.</given-names></name></person-group> (<year>2004</year>). <article-title>Antibacterial resistance worldwide: causes, challenges and responses</article-title>. <source>Nat. Med.</source> <volume>10</volume>, <fpage>S122</fpage>&#x2013;<lpage>S129</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm1145</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lowy</surname> <given-names>F. D.</given-names></name></person-group> (<year>2003</year>). <article-title>Antimicrobial resistance: the example of <italic>Staphylococcus aureus</italic></article-title>. <source>J. Clin. Invest.</source> <volume>111</volume>, <fpage>1265</fpage>&#x2013;<lpage>1273</lpage>. doi: <pub-id pub-id-type="doi">10.1172/jci18535</pub-id>, PMID: <pub-id pub-id-type="pmid">12727914</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makhlin</surname> <given-names>J.</given-names></name> <name><surname>Kofman</surname> <given-names>T.</given-names></name> <name><surname>Borovok</surname> <given-names>I.</given-names></name> <name><surname>Kohler</surname> <given-names>C.</given-names></name> <name><surname>Engelmann</surname> <given-names>S.</given-names></name> <name><surname>Cohen</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Staphylococcus aureus ArcR controls expression of the arginine deiminase operon</article-title>. <source>J. Bacteriol.</source> <volume>189</volume>, <fpage>5976</fpage>&#x2013;<lpage>5986</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.00592-07</pub-id>, PMID: <pub-id pub-id-type="pmid">17557828</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masmoudi</surname> <given-names>S.</given-names></name> <name><surname>Denis</surname> <given-names>M.</given-names></name> <name><surname>Maalej</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Inactivation of the gene katA or sodA affects the transient entry into the viable but non-culturable response of Staphylococcus aureus in natural seawater at low temperature</article-title>. <source>Mar. Pollut. Bull.</source> <volume>60</volume>, <fpage>2209</fpage>&#x2013;<lpage>2214</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.marpolbul.2010.08.017</pub-id>, PMID: <pub-id pub-id-type="pmid">20833402</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mongkolsuk</surname> <given-names>S.</given-names></name> <name><surname>Helmann</surname> <given-names>J. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Regulation of inducible peroxide stress responses</article-title>. <source>Mol. Microbiol.</source> <volume>45</volume>, <fpage>9</fpage>&#x2013;<lpage>15</lpage>. doi: <pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03015.x</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oogai</surname> <given-names>Y.</given-names></name> <name><surname>Kawada-Matsuo</surname> <given-names>M.</given-names></name> <name><surname>Komatsuzawa</surname> <given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Staphylococcus aureus SrrAB affects susceptibility to hydrogen peroxide and co-existence with <italic>Streptococcus sanguinis</italic></article-title>. <source>PLoS One</source> <volume>11</volume>:<fpage>e0159768</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0159768</pub-id>, PMID: <pub-id pub-id-type="pmid">27441894</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>B.</given-names></name> <name><surname>Su</surname> <given-names>Y. B.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Guo</surname> <given-names>C.</given-names></name> <name><surname>Tian</surname> <given-names>Y. M.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title><italic>Exogenous alanine</italic> and/or glucose plus kanamycin kills antibiotic-resistant bacteria</article-title>. <source>Cell Metab.</source> <volume>21</volume>, <fpage>249</fpage>&#x2013;<lpage>262</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2015.01.008</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>V.</given-names></name> <name><surname>Pal</surname> <given-names>A.</given-names></name> <name><surname>Darokar</surname> <given-names>M. P.</given-names></name></person-group> (<year>2021</year>). <article-title>Glabridin synergy with norfloxacin induces ROS in multidrug resistant <italic>Staphylococcus aureus</italic></article-title>. <source>J. Gen. Appl. Microbiol.</source> <volume>67</volume>, <fpage>269</fpage>&#x2013;<lpage>272</lpage>. doi: <pub-id pub-id-type="doi">10.2323/jgam.2021.06.002</pub-id>, PMID: <pub-id pub-id-type="pmid">34690227</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suo</surname> <given-names>B.</given-names></name> <name><surname>Guan</surname> <given-names>P.</given-names></name> <name><surname>Dong</surname> <given-names>Z.</given-names></name> <name><surname>Zeng</surname> <given-names>Y.</given-names></name> <name><surname>Fan</surname> <given-names>S.</given-names></name> <name><surname>Fan</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Comparative transcriptomic analysis of <italic>Staphylococcus aureus</italic> reveals the genes involved in survival at low temperature</article-title>. <source>Foods</source> <volume>11</volume>:<fpage>996</fpage>. doi: <pub-id pub-id-type="doi">10.3390/foods11070996</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van der Veen</surname> <given-names>B. S.</given-names></name> <name><surname>de Winther</surname> <given-names>M. P.</given-names></name> <name><surname>Heeringa</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease</article-title>. <source>Antioxid. Redox Signal.</source> <volume>11</volume>, <fpage>2899</fpage>&#x2013;<lpage>2937</lpage>. doi: <pub-id pub-id-type="doi">10.1089/ars.2009.2538</pub-id>, PMID: <pub-id pub-id-type="pmid">19622015</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname> <given-names>C.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular mechanisms that confer antibacterial drug resistance</article-title>. <source>Nature</source> <volume>406</volume>, <fpage>775</fpage>&#x2013;<lpage>781</lpage>. doi: <pub-id pub-id-type="doi">10.1038/35021219</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>W.</given-names></name> <name><surname>Hsu</surname> <given-names>Y. M.</given-names></name> <name><surname>Bi</surname> <given-names>L.</given-names></name> <name><surname>Songyang</surname> <given-names>Z.</given-names></name> <name><surname>Lin</surname> <given-names>X.</given-names></name></person-group> (<year>2009</year>). <article-title>CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDI-Rac1 complex</article-title>. <source>Nat. Immunol.</source> <volume>10</volume>, <fpage>1208</fpage>&#x2013;<lpage>1214</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni.1788</pub-id>, PMID: <pub-id pub-id-type="pmid">19767757</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <name><surname>Tian</surname> <given-names>Z.</given-names></name> <name><surname>Chen</surname> <given-names>G.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Xia</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Oligoribonuclease contributes to tolerance to aminoglycoside and &#x03B2;-lactam antibiotics by regulating KatA in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>:<fpage>e00212&#x2013;19</fpage>. doi: <pub-id pub-id-type="doi">10.1128/aac.00212-19</pub-id>, PMID: <pub-id pub-id-type="pmid">30936107</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <name><surname>Shirtliff</surname> <given-names>M. E.</given-names></name> <name><surname>Peters</surname> <given-names>B. M.</given-names></name> <name><surname>Li</surname> <given-names>B.</given-names></name> <name><surname>Peng</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Resistance class 1 integron in clinical methicillin-resistant Staphylococcus aureus strains in southern China, 2001-2006</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>17</volume>, <fpage>714</fpage>&#x2013;<lpage>718</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1469-0691.2010.03379.x</pub-id>, PMID: <pub-id pub-id-type="pmid">21521411</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>D.</given-names></name> <name><surname>Deutscher</surname> <given-names>M. P.</given-names></name></person-group> (<year>1995</year>). <article-title>Oligoribonuclease is distinct from the other known exoribonucleases of <italic>Escherichia coli</italic></article-title>. <source>J. Bacteriol.</source> <volume>177</volume>, <fpage>4137</fpage>&#x2013;<lpage>4139</lpage>. doi: <pub-id pub-id-type="doi">10.1128/jb.177.14.4137-4139.1995</pub-id>, PMID: <pub-id pub-id-type="pmid">7608090</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname> <given-names>W. B.</given-names></name> <name><surname>Pan</surname> <given-names>Q.</given-names></name> <name><surname>Ye</surname> <given-names>B. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Glucose-induced cyclic Lipopeptides resistance in bacteria via ATP maintenance through enhanced glycolysis</article-title>. <source>iScience</source> <volume>21</volume>, <fpage>135</fpage>&#x2013;<lpage>144</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.isci.2019.10.009</pub-id>, PMID: <pub-id pub-id-type="pmid">31655254</pub-id></citation></ref>
</ref-list>
</back>
</article>